Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$43,259,725
+$748,432 QoQ
Shares Held
170,334
-2.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#482
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. JNJ ranks #1 (27.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
|
12,976 | $2,033,598 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,259,725 | 170,334 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $42,511,293 | 173,913 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $38,304,375 | 185,090 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $34,909,765 | 188,274 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $28,885,788 | 189,105 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $33,430,193 | 201,581 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $28,165,178 | 194,753 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $31,523,749 | 194,519 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $28,651,452 | 196,028 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $31,561,119 | 199,514 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $31,459,912 | 200,714 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $35,698,523 | 229,204 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $37,495,576 | 226,532 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $34,643,740 | 223,508 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $39,430,576 | 223,213 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $35,776,493 | 219,004 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $38,462,511 | 216,678 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $37,658,007 | 212,481 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $36,972,674 | 216,126 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $34,995,758 | 216,692 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $32,771,728 | 198,930 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $33,395,920 | 203,200 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $31,659,505 | 201,166 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $30,361,693 | 203,934 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $28,923,793 | 205,673 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $27,481,700 | 209,576 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||